Metabolic Control of GP-led Hypertensive Type 2 Diabetes Patients on Oral Antidiabetic Drugs

Objectives: To assess the metabolic status of hypertensive type 2 diabetes patients on oral antidiabetic drugs (OADs) while managed by general practitioners (GPs).Methods: 82 GPs agreed to provide patient data for retrospective analysis.The patients' inclusion criteria were: 1/ Age ≥ 40 years; 2/ Type 2 diabetes for >1 year; 3/ Treatment with OADs >3 months; 4/Arterial hypertension for >1 year; 5/ Stable doses of antihypertensive drugs for >3 months.Exclusion criteria were Type 1 diabetes, injectable antidiabetic treatments.Data were introduced in a specific electronic registry by the GPs themselves.An IBM SPSS 19.0 package was used for statistical analysis.Results: 5 926 patients' records met the entry criteria.7.6% were aged 40 to 50 years; 22.6% -51 to 60, 39.4% -61 to 70. 53.75% were women.Normal BMI, overweight and obesity grade I -III were found in 16.2%, 42.1%, 27.6%, 9.7% and 4.2%.The waist circumference was <94 cm in 26.4% of men; and <80 cm in 10.7% of women.Fasting plasma glucose was ≤ 6.0 mmol/l in 19.2%; and ≤ 7.0 mmol/l -in 50.4%.Glycated hemoglobin was ≤ 7.0% in 62.9%; and ≤ 8.0% in 87.0%.The LDL-C was <1.8 mmol/l in 9.1%; and 1.8 to 2.6 mmol/l -in 19.6%.The blood pressure was <140/90 mm Hg in 77.4% of the patients. Conclusions:The data about the glycated hemoglobin and the control of blood pressure are reassuring.An improvement is needed in controlling obesity and dyslipidemia.